Editing Gates Foundation (section)

=== COVID-19 ===
Beginning in 2020, the Bill & Melinda Gates Foundation has provided hundreds of millions of dollars of funding towards initiatives surrounding the [[COVID-19 pandemic|COVID-19 public health crisis]].

==== COVID-19 Therapeutics Accelerator ====
In 2020, together with the UK research charity [[Wellcome]] and [[Mastercard International Global Headquarters|Mastercard]], the Gates Foundation established the [[COVID-19]] Therapeutics Accelerator to hasten the development and evaluation of new and repurposed drugs and biologics to treat patients for [[COVID-19]].<ref>{{Cite web |url=https://www.goodnewsnetwork.org/gates-foundation-commits-100-million-to-coronavirus-response/ |title=Gates Foundation Commits $100 Million to Speeding Up Coronavirus Treatments and Response |date=March 10, 2020 |website=Good News Network |language=en-US |access-date=March 15, 2020 |archive-date=March 11, 2020 |archive-url=https://web.archive.org/web/20200311031639/https://www.goodnewsnetwork.org/gates-foundation-commits-100-million-to-coronavirus-response/ |url-status=live }}</ref> After the [[World Health Organization]]'s appeal for funding, the Gates Foundation pledged an extra US$150 million on top of the US$100 million already committed earlier.{{cn|date=November 2024}}

By April 2020, the foundation had provided backing for six candidates for vaccines against COVID-19.<ref>{{Cite web |last=Varshney |first=Neer |date=2020-04-27 |title=Bill Gates, Backer of Inovio And Six Others, Says Coronavirus Vaccine Could Be Mass Produced Within A Year |url=https://finance.yahoo.com/news/bill-gates-backer-inovio-six-074230868.html |url-status=live |archive-url=https://archive.today/20220410093022/https://finance.yahoo.com/news/bill-gates-backer-inovio-six-074230868.html?guccounter=1 |archive-date=2022-04-10 |access-date=2022-06-14 |website=[[Yahoo! Finance]] |language=en-US}}</ref> In June, the foundation tapped the [[National University of Singapore]] to investigate which countries in [[Asia]] responded effectively to the pandemic.<ref>{{Cite web |date=June 2020 |title=National University of Singapore |url=https://www.gatesfoundation.org/about/committed-grants/2020/06/inv005598 |url-status=live |archive-url=https://archive.today/20220615022639/https://www.gatesfoundation.org/about/committed-grants/2020/06/inv005598 |archive-date=2022-06-15 |access-date=2022-06-15 |website=Bill & Melinda Gates Foundation |language=en}}</ref> On June 26, the foundation and its partners with the COVID-19 Therapeutics Accelerator announced the launch of the International COVID-19 Data Alliance (ICODA) to be hosted at Health Data Research UK.<ref>{{Cite web |date=2020-06-26 |title=COVID-19 Therapeutics Accelerator Donors Launch International Alliance to Connect Research Data Sources and Enable Collaboration |url=https://www.gatesfoundation.org/ideas/media-center/press-releases/2020/06/covid-19-therapeutics-accelerator-donors-launch-international-alliance |url-status=live |archive-url=https://web.archive.org/web/20210414083155/https://www.gatesfoundation.org/Ideas/Media-Center/Press-Releases/2020/06/COVID-19-Therapeutics-Accelerator-Donors-Launch-International-Alliance |archive-date=2021-04-14 |access-date=2022-10-01 |website=Bill & Melinda Gates Foundation |language=en}}</ref>

In December 2020, the foundation solicited applications for funding for researchers at [[McMaster University]] to develop [[epidemiological models]] for [[SARS-CoV-2]], as well as [[COVID-19 vaccine]]s, [[Covid-19 treatment|treatments]] and [[Non-pharmaceutical intervention (epidemiology)|non-pharmaceutical interventions]].<ref>{{Cite web |title=Bill & Melinda Gates Foundation: Grand Challenges ICODA COVID-19 Data Science |url=https://research.mcmaster.ca/funding/grand-challenges-icoda-covid-19-data-science-initiative/ |url-status=live |archive-url=https://archive.today/20211201212030/https://research.mcmaster.ca/funding/grand-challenges-icoda-covid-19-data-science-initiative/ |archive-date=2021-12-01 |access-date=2022-06-10 |website=[[McMaster University]] Research & Innovation |language=en-US}}</ref> The foundation re-upped its support of ICODA in May 2021 with a grant of $577,246.<ref>{{Cite web |date=May 2021 |title=Health Data Research UK |url=https://www.gatesfoundation.org/about/committed-grants/2021/05/inv033701 |url-status=live |archive-url=https://archive.today/20221001073727/https://www.gatesfoundation.org/about/committed-grants/2021/05/inv033701 |archive-date=2022-10-01 |access-date=2022-10-01 |website=Bill & Melinda Gates Foundation |language=en}}</ref>

In August 2021, the foundation awarded a $587,568 grant to Wits Health Consortium to test the effectiveness of the [[COVID-19 vaccine]]s distributed in [[South Africa]] by [[Johnson & Johnson]] and [[Pfizer]].<ref>{{Cite web |date=August 2021 |title=Wits Health Consortium (Pty) Ltd |url=https://www.gatesfoundation.org/about/committed-grants/2021/08/inv035995 |url-status=live |archive-url=https://web.archive.org/web/20211119093632/https://www.gatesfoundation.org/about/committed-grants/2021/08/inv035995 |archive-date=2021-11-19 |access-date=2022-06-14 |website=Bill & Melinda Gates Foundation |language=en}}</ref>

In November 2021, the foundation gave $2,118,334 to [[Providence Therapeutics]] to develop more cost-effective [[mRNA vaccine]]s.<ref>{{Cite web |date=November 2021 |title=Providence Therapeutics |url=https://www.gatesfoundation.org/about/committed-grants/2021/11/inv036094 |url-status=live |archive-url=https://archive.today/20220614010933/https://www.gatesfoundation.org/about/committed-grants/2021/11/inv036094 |archive-date=2022-06-14 |access-date=2022-06-14 |website=Bill & Melinda Gates Foundation |language=en}}</ref>